Advertisement

Topics

Neuromod Devices Limited Company Profile

03:28 EDT 23rd October 2018 | BioPortfolio

Neuromod, headquartered in the Digital Hub, Dublin, Ireland, is an emerging medical technology company, specialising in the design and development of neuromodulation technologies to address the clinical needs of underserved patient populations who live with chronic and debilitating conditions. The company was founded in 2010, by Dr. Ross O’Neill, as a spin-out from Maynooth University. The lead application of Neuromod’s technology is in the field of tinnitus, where Neuromod is conducting extensive clinical trials to confirm the efficacy of its non-invasive neuromodulation platform in this common disorder for which no standard of care has yet been established. Tinnitus affects between 10 and 15% of the global population, and the lives of at least 1 in every 100 people worldwide are severely compromised because of the incessant nature of the illusory sound that is often described as a ringing or buzzing in the ears.


News Articles [475 Associated News Articles listed on BioPortfolio]

Neuromod Welcomes Hearing Industry Leader

Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specialising in non-invasive neuromodulation technologies, is pleased to announce that Mr. Christoph...

Plug-and-play diagnostic devices

(Massachusetts Institute of Technology) Researchers at MIT's Little Devices Lab have developed modular blocks that can be put together in different ways to produce diagnostic devices. These 'plug-and-...

Medibio Broadens Opportunities with Compatibility to Fitbit Wearable Devices for Mental Health Measurement

Fitbit joins Apple Watch, Garmin and others allowing users to help process biometric data for an objective view of mental health SYDNEY, Australia and MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE)...

Mechanical Colonoscopy Detection Devices Better Than Wide-Angle Viewing

For improving mucosal exposure, mechanical devices outperformed optical devices in a meta-analysis.

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

[Health Policy] The need for transparency of clinical evidence for medical devices in Europe

To use medical devices rationally, health-care professionals must base their choices of which devices to recommend for individual patients on an objective appraisal of their safety and clinical effica...

Guest Article: The benefits of interfacing computers to medical devices

This is a guest article, written by Nicholas Cain, CEO of Cain Medical. Cain Medical is the developer of CMSense, a solution for integrating multiple medical devices into legacy or modern health IT ap...

PubMed Articles [719 Associated PubMed Articles listed on BioPortfolio]

Cardiac rhythm management devices

The last decade has seen ongoing evolution and use of cardiac rhythm management devices, including pacemakers, cardiac resynchronisation therapy, implantable cardioverter defibrillators and loop recor...

The regulatory ancestral network of surgical meshes.

All surgical meshes entering the U.S. market have been cleared for clinical use by the 510(k) process of the Food and Drug Administration (FDA), in which devices simply require proof of "substantial e...

Cecal Resection with Bipolar Sealing Devices in a Rat Model.

Bipolar sealing devices are routinely used to seal blood vessels. The aim of the study is to evaluate the feasibility and safety of colonic sealing with the use of the bipolar energy devices in rats a...

Patch Pumps for Insulin.

Newly developed patch pumps are starting to occupy a noticeable fraction of the insulin delivery market. New entrants, using novel technologies, promise accurate, flexible insulin delivery at lower co...

Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

In the last two decades, the increased number of implants of cardiac implantable electronic devices has been accompanied by an increase in complications, especially infection. Current recommendations ...

Clinical Trials [1068 Associated Clinical Trials listed on BioPortfolio]

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Transvenous Lead Removal Post-Market Clinical Study

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook cathet...

Glottic View Using Supraglottic Devices in Pediatric Patients

Endotracheal intubation is the gold standard for securing the airway. However, while managing patients with difficult airways, various supraglottic devices have been used as rescue airway ...

A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid

This cross-over study of 12 patients with sarcoidosis will look at two different widely-used accelerometer devices. These devices are wrist worn and similar in size to a wrist-watch. They ...

Participatory Organizational Intervention for Improved Use of Assistive Devices for Patient Handling

Epidemiological studies have shown that patient transfer is a risk factor for back pain, back injuries and long term sickness absence, whereas consistent use of assistive devices during pa...

Companies [1108 Associated Companies listed on BioPortfolio]

Neuromod Devices Limited

Neuromod, headquartered in the Digital Hub, Dublin, Ireland, is an emerging medical technology company, specialising in the design and development of neuromodulation technologies ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Neuromod

Toumaz Limited

Toumaz Limited is an AIM-listed group focused on opportunities in medical devices, healthcare IT and consumer electronics. Based on a portfolio of unique and world-leading silicon chip technologies,...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Neuromod Devices Limited" on BioPortfolio

We have published hundreds of Neuromod Devices Limited news stories on BioPortfolio along with dozens of Neuromod Devices Limited Clinical Trials and PubMed Articles about Neuromod Devices Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuromod Devices Limited Companies in our database. You can also find out about relevant Neuromod Devices Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record